[go: up one dir, main page]

CA2343572A1 - Marqueur au niveau du gene recepteur de la vitamine d, utilise pour la determination de la sensibilite au cancer du sein - Google Patents

Marqueur au niveau du gene recepteur de la vitamine d, utilise pour la determination de la sensibilite au cancer du sein Download PDF

Info

Publication number
CA2343572A1
CA2343572A1 CA002343572A CA2343572A CA2343572A1 CA 2343572 A1 CA2343572 A1 CA 2343572A1 CA 002343572 A CA002343572 A CA 002343572A CA 2343572 A CA2343572 A CA 2343572A CA 2343572 A1 CA2343572 A1 CA 2343572A1
Authority
CA
Canada
Prior art keywords
breast cancer
vitamin
marker
receptor gene
cancer susceptibility
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA002343572A
Other languages
English (en)
Other versions
CA2343572C (fr
Inventor
Francois Rousseau
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Universite Laval
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2343572A1 publication Critical patent/CA2343572A1/fr
Application granted granted Critical
Publication of CA2343572C publication Critical patent/CA2343572C/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/136—Screening for pharmacological compounds
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/172—Haplotypes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Hospice & Palliative Care (AREA)
  • Biophysics (AREA)
  • Oncology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
CA002343572A 1998-09-15 1999-09-15 Marqueur au niveau du gene recepteur de la vitamine d, utilise pour la determination de la sensibilite au cancer du sein Expired - Fee Related CA2343572C (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US10044898P 1998-09-15 1998-09-15
US60/100,448 1998-09-15
PCT/CA1999/000853 WO2000015835A2 (fr) 1998-09-15 1999-09-15 Marqueur au niveau du gene recepteur de la vitamine d, utilise pour la determination de la sensibilite au cancer du sein

Publications (2)

Publication Number Publication Date
CA2343572A1 true CA2343572A1 (fr) 2000-03-23
CA2343572C CA2343572C (fr) 2008-01-22

Family

ID=22279822

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002343572A Expired - Fee Related CA2343572C (fr) 1998-09-15 1999-09-15 Marqueur au niveau du gene recepteur de la vitamine d, utilise pour la determination de la sensibilite au cancer du sein

Country Status (4)

Country Link
EP (1) EP1114180A2 (fr)
AU (1) AU5723299A (fr)
CA (1) CA2343572C (fr)
WO (1) WO2000015835A2 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6270094B1 (en) 1999-03-26 2001-08-07 William F. Campbell Multi-purpose wire dispensing cart

Also Published As

Publication number Publication date
WO2000015835A3 (fr) 2000-07-13
CA2343572C (fr) 2008-01-22
WO2000015835A2 (fr) 2000-03-23
AU5723299A (en) 2000-04-03
EP1114180A2 (fr) 2001-07-11

Similar Documents

Publication Publication Date Title
US5636292C1 (en) Steganography methods employing embedded calibration data
AU5212199A (en) Methods and kits for diagnosing and determination of the predisposition of diseases
WO2002024956A8 (fr) Marqueurs genetiques de tumeurs
AU5324099A (en) Methods for predicting drug response
AU2543599A (en) Exercise tracking system
AU7277698A (en) Integrated disease information system
AU5132999A (en) Method of grouping and analyzing clinical risks, and system therefor
AU4229899A (en) Methods for determining breast cancer and melanoma by assaying for a plurality of antigens associated therewith
DE69815298D1 (de) Teilchen mit polyaldehyd-dextran-überzug, die verkleinerte matrixeffekte aufweisen
AU1707999A (en) Detection of prostate disease by measuring naaladase activity
EP0837872A4 (fr) Systeme de selection genetique base sur la cytotoxicite (toxsel)
AU6257298A (en) Breast cancer specific gene 1
MXPA02002251A (es) Diagnosticos y terapeuticos para osteoporosis.
WO2002099853A3 (fr) Support de tranche a commande de temperature et procede de commande de la temperature d'un objet sensiblement plat
AU5123596A (en) Method for detecting breast cancer cells
DE69923628D1 (de) 3,4-Dihydroxy-2-butanone 4-Phosphate Synthase
WO2000022122A3 (fr) Genes, proteines et marqueurs bialleliques lies a une maladie du systeme nerveux central
AU1367201A (en) Method and system for providing genotype clinical information over a computer network
CA2343572A1 (fr) Marqueur au niveau du gene recepteur de la vitamine d, utilise pour la determination de la sensibilite au cancer du sein
WO2000015834A3 (fr) Marqueur au niveau du gene recepteur des hormones androgenes pour la determination de la sensibilite au cancer du sein
ZA988025B (en) Method for enhancing the activity of an enzyme.
WO2000015836A3 (fr) Combinaison de marqueurs au niveau des genes recepteurs des oestrogenes et de la vitamine d, ou equivalents de ces derniers, pour le pronostic d'une reponse au traitement de l'osteoporose
WO2001004343A3 (fr) Procede permettant d'etablir un pronostic pour des patients atteints d'un cancer, par mesure des niveaux d'expression de la proteine bag
AU5298696A (en) Tumor marker protein for cancer risk assessment
AU2002341044A1 (en) Methods for detecting parkinson's disease

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed

Effective date: 20160915